Department of Clinical Sciences, The Ohio State University, College of Veterinary Medicine, Columbus, OH 43210, USA.
Equine Vet J. 2010 Apr;42(3):261-9. doi: 10.2746/042516409X475760.
Laminitis is a serious complication of horses suffering from sepsis/endotoxaemia-related events. Laminitis in horses and organ injury in human sepsis are both reported to involve inflammatory injury to the laminae/organs including early activation of endothelium and leucocytes leading to emigration of neutrophils into the tissue interstitium. In the black walnut extract (BWE) model, systemic inflammatory events coincide with marked increase in laminar mRNA concentrations of inflammatory genes including proinflammatory cytokines (i.e. IL-1beta, IL-6), COX-2, chemokines (i.e. IL-8) and endothelial adhesion molecules (i.e. ICAM-1 and E-selectin). In models of human sepsis, i.v. lidocaine has been reported to decrease leucocyte and endothelial activation, and the expression of proinflammatory cytokines and chemokines.
To evaluate the effect of i.v. lidocaine therapy on the inflammatory processes documented to occur in the BWE model of laminitis.
Twelve horses were administered BWE and treated immediately with either lidocaine (1.3 mg/kg bwt bolus, followed by 0.05 mg/kg bwt/min CRI, n=6) or saline (n=6) for 10 h. At 10 h post BWE administration, laminar samples were obtained under general anaesthesia for assessment of proinflammatory gene expression (using RT-qPCR) and leucocyte emigration (via CD13 immunohistochemistry). At 0, 3 and 10 h post BWE administration, skin samples were obtained for assessment of leucocyte emigration (via calprotectin immunohistochemistry).
No significant differences between groups were noted for inflammatory gene mRNA concentrations (IL-1beta, IL-6, IL-8, COX-2) or for number of leucocytes present within the laminar interstitium or skin dermis. Increased (P<0.05) laminar E-selectin mRNA concentrations were present in the LD group (vs. SAL group).
Continuous administration of i.v. lidocaine does not inhibit inflammatory events in either the laminae or skin in the horse administered black walnut extract.
This work questions the use of continuous i.v. administration of lidocaine as an effective anti-inflammatory therapy for systemic inflammation.
马蹄叶炎是患有脓毒症/内毒素血症相关疾病的马匹的严重并发症。据报道,马蹄叶炎和人类脓毒症中的器官损伤都涉及到蹄叶组织和器官的炎症损伤,包括内皮细胞和白细胞的早期激活,导致中性粒细胞向组织间质迁移。在黑胡桃提取物(BWE)模型中,全身性炎症事件与明显增加的炎症基因 mRNA 浓度同时发生,包括促炎细胞因子(如 IL-1beta、IL-6)、COX-2、趋化因子(如 IL-8)和内皮细胞黏附分子(如 ICAM-1 和 E-选择素)。在人类脓毒症模型中,静脉内给予利多卡因已被报道可减少白细胞和内皮细胞的激活,以及促炎细胞因子和趋化因子的表达。
评估静脉内给予利多卡因治疗对蹄叶炎 BWE 模型中发生的炎症过程的影响。
12 匹马给予 BWE,并立即给予利多卡因(1.3mg/kg bwt 推注,然后以 0.05mg/kg bwt/min CRI 给予,n=6)或生理盐水(n=6)治疗 10 小时。在给予 BWE 后 10 小时,在全身麻醉下获取蹄叶组织样本,用于评估促炎基因表达(使用 RT-qPCR)和白细胞迁移(通过 CD13 免疫组化)。在给予 BWE 后 0、3 和 10 小时,获取皮肤样本,用于评估白细胞迁移(通过钙卫蛋白免疫组化)。
两组之间的炎症基因 mRNA 浓度(IL-1beta、IL-6、IL-8、COX-2)或蹄叶组织间质或皮肤真皮内存在的白细胞数量无显著差异。LD 组的 E-选择素 mRNA 浓度增加(P<0.05)(与 SAL 组相比)。
连续静脉内给予利多卡因不能抑制给予黑胡桃提取物的马匹的蹄叶和皮肤中的炎症事件。
这项工作质疑连续静脉内给予利多卡因作为全身性炎症的有效抗炎治疗的用途。